Abstract | OBJECTIVE: DESIGN: 7-14 treatment days, prospective, randomised, open study. PATIENTS: INTERVENTION: 7-14 days of topical non-steroidal anti-inflammatory drugs treatment to assess the pain intensity changes (daily activities and spontaneous at rest) in a daily diary (100-mm Visual Analogue Scale (VAS)). MAIN OUTCOME MEASUREMENT: RESULTS: The ketoprofen patch was not inferior to diclofenac gel in reducing the baseline pain during daily activities (difference of -1.17 mm in favour of ketoprofen patch, 95% CI (-5.86 to 3.52), reducing to the baseline VAS 79%. Ketoprofen patch presented also a higher cure rate (64%) than diclofenac gel (46%) at day 7 (p = 0.004). Patient opinions about the treatment comfort ( pharmaceutical shape, application and dosage) were also statistically higher for the ketoprofen patch (>80% of the patients rated as good or excellent the patch removal and skin adherence). CONCLUSION:
|
Authors | Francisco Esparza, César Cobián, José Fernando Jiménez, Juan José García-Cota, Carlos Sánchez, Antonio Maestro, Working group for the acute pain study of SETRADE |
Journal | British journal of sports medicine
(Br J Sports Med)
Vol. 41
Issue 3
Pg. 134-9
(Mar 2007)
ISSN: 1473-0480 [Electronic] England |
PMID | 17138642
(Publication Type: Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Gels
- Diclofenac
- Ketoprofen
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, therapeutic use)
- Athletic Injuries
(drug therapy)
- Diclofenac
(adverse effects, therapeutic use)
- Female
- Gels
- Humans
- Ketoprofen
(adverse effects, therapeutic use)
- Male
- Middle Aged
- Pain
(drug therapy, etiology)
- Prospective Studies
- Soft Tissue Injuries
(drug therapy, etiology)
- Treatment Outcome
|